Saturday, September 12, 2026

7:30 - 8:30 AM	REGISTRATION & BREAKFAST
8:30 - 8:35 AM	Announcements Tulio Rodriguez, MD
8:35 - 8:40 AM	Welcome Walter Stadler, MD
8:40 - 8:50 AM	Navigating Controversies in Modern Cancer Care When Evidence Meets Clinical Judgement Tulio Rodriguez, MD
8:50 - 9:15 AM	Should High-Risk Smoldering Myeloma be Routinely Treated? Tulio Rodriguez, MD
9:15 - 9:40 AM	Double-Hit Lymphoma: Do We Still Need Intensified Chemotherapy? Leslie Popplewell, MD
9:40 - 10:05 AM	CAR-T vs Bispecific Antibodies in Earlier Lines of Therapy Jacob Bitran, MD
10:05 - 10:20 AM	BREAK
10:20 - 10:45 AM	Making Sense of Many Options & Keeping the Patient at the Center: Newly Diagnosed Metastatic Prostate Cancer Tanya Barauskas Dorff, MD
10:45 - 11:10 AM	Managing Oligometastatic Disease: Aggressive Local Therapy or Systemic-First Approach Ajaz M. Khan, MD
11:10 - 11:35 AM	Radiation Plus Immunotherapy: Synergy or Added Toxicity? Karan Shah, MD, MBA
11:35 AM - 12:00 PM	Renal Cancer: Which Drug(s), When, and For Whom? Walter Stadler, MD
12:00 - 12:35 PM	LUNCH
12:35 - 1:00 PM	Intensive Induction vs Azacitidine/Venetoclax for Older but Fit Patients with Acute Myeloid Leukemia Aileen Go, MD
1:00 - 1:25 PM	Bringing Cellular Therapy to Melanoma: The City of Hope Experience with Tumor-Infiltrating Lymphocyte (TIL) Therapy Kelly Mahuron, MD
1:25 - 2:30 PM	Panel Discussion: Cross-Disciplinary Controversies in Cancer Care Moderator: Tulio Rodriguez, MD Panelists: Walter Stadler, MD — Genitourinary Oncology Tanya Dorff, MD — Genitourinary Oncology Leslie Popplewell, MD — Lymphoma/Hematologic Malignancies Aileen Go, MD — Leukemia/Cellular Therapy Karan Shah, MD, MBA — Radiation Oncology
2:30 - 3:00 PM	Closing Discussion & Key Takeaways Tulio Rodriguez, MD
3:00 PM	ADJOURN

 AJCC CANCER STAGING FORMS For any disease-specific updates, please click here.